Fluorinated cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents

Cyclometalated iridium(iii) complexes bearing different numbers of fluorine atoms were developed to induce apoptosis via mitochondrial pathways and demonstrated much better anticancer activities than the widely used clinical chemotherapeutic agent cisplatin.